2020 to 2023 Saw Sharp Increase in Nicotine Pouch Ingestions in Children
By Elana Gotkine HealthDay Reporter

THURSDAY, July 17, 2025 -- Nicotine pouch ingestions increased 763.1 percent among children from 2020 to 2023, according to a study published online July 14 in Pediatrics.
Madelyn Olivas, from the Abigail Wexner Research Institute at Nationwide Children's Hospital in Columbus, Ohio, and colleagues analyzed unintentional, single-substance nicotine ingestions among children younger than age 6 years reported to the National Poison Data System from 2010 to 2023. The authors sought to identify the characteristics and trends of nicotine ingestions.
The researchers identified 134,663 nicotine ingestions among children younger than age 6 years reported to U.S. poison centers; most were among children younger than 2 years, were among boys, or occurred at a residence (76.2, 55.5, and 98.5 percent, respectively). From 2010 to 2015, there was an increase in the rate of nicotine ingestions by 59.4 percent, followed by a decrease of 34.1 percent from 2015 to 2023. This rate trend was mainly due to the ingestion rate for liquid nicotine, which increased 450.0 percent from 2010 to 2015, followed by a 45.2 percent decrease from 2015 to 2023. From 2020 to 2023, there was an increase of 763.1 percent in the rate of nicotine pouch ingestions. Compared with other nicotine product formulations combined, nicotine pouches were more likely to be associated with a serious medical outcome or medical admission (odds ratios, 1.53 and 2.03, respectively).
"Banning flavors in all nicotine products helps reduce unintentional ingestions by young children as well as discourage use among teens," senior author Gary Smith, M.D., Dr.P.H., also from The Abigail Wexner Research Institute, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-18 12:00
Read more

- Nearly 30 People in England Get Rare Illness After Botox
- Rheumatoid Arthritis Patients Benefit From Blood Flow-Restricted Strength Training
- Measles Outbreak in Kentucky Confirmed
- Lilly's Oral GLP-1, Orforglipron, Showed Compelling Efficacy and a Safety Profile Consistent with Injectable GLP-1 Medicines, in Complete Phase 3 Results
- Considerable Variation Seen in Commercial Pricing for Surgery Services
- Experts Sound Alarm About Risk of Child Deaths in Hot Cars
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions